Inventor · disambiguated record
Xinshan Kang
Also filed as: KANG XINSHAN
11 granted patents·2 pending applications·299 citations·filing 2007–2019
90Inventor score
Files withKANG XINSHAN5SENOMYX INC3FUJIAN HAIXI PHARMACEUTICALS CO LTD2TACHDJIAN CATHERINE2SERVANT GUY1
Top patents by PatentIndex Score
13 records- 0197US8541421B2Methods of enhancing sweet taste of compositions using substituted thieno{2,3-D}pyrimidinesTACHDJIAN CATHERINE·Filed 2011·Granted Sep 24, 2013·114 cites·15 claims
- 0296US8633186B2Modulation of chemosensory receptors and ligands associated therewithTACHDJIAN CATHERINE·Filed 2008·Granted Jan 21, 2014·67 cites·16 claims
- 0396US7928111B2Compounds including substituted thienopyrimidinone derivatives as ligands for modulating chemosensory receptorsSENOMYX INC·Filed 2007·Granted Apr 19, 2011·60 cites·14 claims
- 0494US9603848B2Modulation of chemosensory receptors and ligands associated therewithSERVANT GUY·Filed 2007·Granted Mar 28, 2017·24 cites·48 claims
- 0593US9181276B2Modulation of chemosensory receptors and ligands associated therewithSENOMYX INC·Filed 2013·Granted Nov 10, 2015·26 cites·35 claims
- 0677US9206134B2Polymorphic forms of compounds as prolyl hydroxylase inhibitor, and uses thereofKANG XINSHAN·Filed 2012·Granted Dec 8, 2015·6 cites·36 claims
- 0765US9238637B2Stable polymorphic forms of compound as hypoxia mimetics, and uses thereofKANG XINSHAN·Filed 2012·Granted Jan 19, 2016·1 cites·9 claims
- 0865US8742138B2Compounds as hypoxia mimetics, and compositions and uses thereofKANG XINSHAN·Filed 2010·Granted Jun 3, 2014·1 cites·49 claims
- 0956US2008306076A1Modulation of chemosensory receptors and ligands associated therewithSENOMYX INC·Filed 2007·Application pending·0 cites
- 1042US11247977B2Compound and use thereof in synthesis of brivaracetam intermediate and crude drugFUJIAN HAIXI PHARMACEUTICALS CO LTD·Filed 2019·Granted Feb 15, 2022·0 cites·13 claims
- 1137US9409900B2Compound for increasing kinase active and application thereofKANG XINSHAN·Filed 2011·Granted Aug 9, 2016·0 cites·24 claims
- 1236US11767296B2Heteroaryl compounds as kinase inhibitorFUJIAN HAIXI PHARMACEUTICALS CO LTD·Filed 2019·Granted Sep 26, 2023·0 cites·10 claims
- 1336US2016200734A1Carboxylic acid compounds in treatment of diabetes mellitusKANG XINSHAN·Filed 2014·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Xinshan Kang files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →